Trisenox and white blood cell count decreased Patient Reports February 13, 2012

Trisenox Side Effects Report #4591872-9
Trisenox side effect was reported by a Physician from on Nov 02, 2004. Female patient, 66 years of age, was diagnosed with myelodysplastic syndrome and was treated with Trisenox. After drug was administered, patient experienced the following side effects: feeling abnormal, fluid retention, haematocrit decreased, oedema, platelet count decreased, retinoic acid syndrome, white blood cell count decreased. Trisenox dosage: 0.25 MG/KG (0.25 MG/KG, 5 DOSE LOAD), IVI. Patient was hospitalized. Patient recovered.

Trisenox Side Effects Report #4621604-7
Trisenox side effect was reported by a Consumer or non-health professional from on Mar 11, 2005. Male patient, 90 years of age, was diagnosed with multiple myeloma

and was treated with Trisenox. After drug was administered, patient experienced the following side effects: abdominal mass, abdominal pain

, herpes zoster, neutropenia, pyrexia, white blood cell count decreased. Trisenox dosage: (0.25 MG/KG, DAILY) IVI. During the same period patient was treated with ASCORBIC ACID, MELPHALAN, ALOXI, AREDIA, KYTRIL, ARANESP, NEUPOGEN, DECADRON. Patient was hospitalized. Patient recovered.

Trisenox Side Effects Report #4712479-6
Trisenox side effect was reported by a Consumer or non-health professional from UNITED STATES on June 20, 2005. Female patient, 70 years of age, weighting 126.0 lb, was diagnosed with multiple myeloma

and was treated with Trisenox. After drug was administered, patient experienced the following side effects: asthenia, cardiac failure congestive, dyspnoea, platelet count decreased, pyrexia, rash

, white blood cell count decreased. Trisenox dosage: 14 MG IVI. During the same period patient was treated with MELPHALAN, ASCORBIC ACID, OXYTROL, SANTURA, FOLIC ACID. Patient was hospitalized. Patient recovered.

Trisenox Side Effects Report #5093427-9
Trisenox side effect was reported by a Physician from JAPAN on Aug 16, 2006. Female patient, 84 years of age, was diagnosed with acute promyelocytic leukaemia and was treated with Trisenox. After drug was administered, patient experienced the following side effects: groin pain, pain in extremity, pyrexia, white blood cell count decreased. Trisenox dosage: 5 MG 0.13MG/KG/DAY QD INTRAVENOUS DRIP. During the same period patient was treated with NICORANDIL, FUROSEMIDE, VORICONAZOLE, FAMOTIDINE. Patient recovered.

Trisenox Side Effects Report #5125022-7
Trisenox side effect was reported by a Physician from JAPAN on Sept 26, 2006. Female patient, 84 years of age, was diagnosed with acute promyelocytic leukaemia and was treated with Trisenox. After drug was administered, patient experienced the following side effects: hypokalaemia, white blood cell count decreased. Trisenox dosage: 7.755 MG QD INTRAVENOUS DRIP. Patient was hospitalized. Patient recovered.

Trisenox Side Effects Report #5022383-4
Trisenox side effect was reported by a Physician from JAPAN on May 30, 2006. Female patient, 84 years of age, was diagnosed with acute promyelocytic leukaemia and was treated with Trisenox. After drug was administered, patient experienced the following side effects: c-reactive protein increased, hypokalaemia, platelet count decreased, white blood cell count decreased. Trisenox dosage: 4.1 MG QD INTRAVENOUS DRIP. During the same period patient was treated with FUROSEMIDE, MEXILETINE HYDROCHLORIDE, NIFEDIPINE, NIZATIDINE, INSULIN. Patient was hospitalized. Patient recovered.

Trisenox Side Effects Report #5029162-2
Trisenox side effect was reported by a Physician from JAPAN on May 31, 2006. Female patient, 84 years of age, was diagnosed with acute promyelocytic leukaemia and was treated with Trisenox. After drug was administered, patient experienced the following side effects: acute promyelocytic leukaemia, c-reactive protein increased, haemoglobin decreased, hypokalaemia, malignant neoplasm progression, platelet count decreased, white blood cell count decreased. Trisenox dosage: 4.1 MG QD INTRAVENOUS DRIP. During the same period patient was treated with FUROSEMIDE, MEXILETINE HYDROCHLORIDE, NIFEDIPINE, NIZATIDINE, INSULIN. Patient was hospitalized. Patient recovered.

Trisenox Side Effects Report #4998496-X
Trisenox side effect was reported by a Physician from JAPAN on Apr 26, 2006. Female patient, 75 years of age, was diagnosed with acute promyelocytic leukaemia and was treated with Trisenox. After drug was administered, patient experienced the following side effects: white blood cell count decreased. Trisenox dosage: 7.65 MG QD INTRAVENOUS DRIP. During the same period patient was treated with GABEXATE MESILATE, CEFEPIME DIHYDROCHLORIDE, MICAFUNGIN. Patient was hospitalized. Patient recovered.

Trisenox Side Effects Report #5002364-7
Trisenox side effect was reported by a Physician from JAPAN on Apr 28, 2006. Female patient, 75 years of age, was diagnosed with acute promyelocytic leukaemia and was treated with Trisenox. After drug was administered, patient experienced the following side effects: white blood cell count decreased. Trisenox dosage: 7.65 MG QD INTRAVENOUS DRIP. During the same period patient was treated with GABEXATE MESILATE, CEFEPIME DIHYDROCHLORIDE, MICAFUNGIN, LEVOFLOXACIN. Patient was hospitalized. Patient recovered.

Trisenox Side Effects Report #5062859-7
Trisenox side effect was reported by a Physician from JAPAN on July 12, 2006. Male patient, 73 years of age, was diagnosed with acute promyelocytic leukaemia and was treated with Trisenox. After drug was administered, patient experienced the following side effects: acute promyelocytic leukaemia, malignant neoplasm progression, neutrophil count decreased, white blood cell count decreased. Trisenox dosage: 9.353 MG QD INTRAVENOUS DRIP. During the same period patient was treated with FAMOTIDINE, CANDESARTAN CILEXETIL. Patient recovered.

Trisenox Side Effects Report #4701597-4
Trisenox side effect was reported by a Physician from on June 07, 2005. Female patient, 73 years of age, was diagnosed with acute promyelocytic leukaemia and was treated with Trisenox. After drug was administered, patient experienced the following side effects: erythema, hot flush, platelet count decreased, white blood cell count decreased. Trisenox dosage: 6.99 MG (6.99 MG, QD), IVI. During the same period patient was treated with SULFAMETHOXAZOLE, TRIMETHOPRIM, POLYMYXIN B SULPHATE. Patient was hospitalized. Patient recovered.

Trisenox Side Effects Report #5024916-0
Trisenox side effect was reported by a Physician from JAPAN on May 24, 2006. Male patient, 73 years of age, was diagnosed with acute promyelocytic leukaemia and was treated with Trisenox. After drug was administered, patient experienced the following side effects: activated partial thromboplastin time prolonged, cerebral haemorrhage, disease progression, fibrin d dimer increased, white blood cell count decreased. Trisenox dosage: 8.625 MG QD INTRAVENOUS DRIP. During the same period patient was treated with ALLOPURINOL, GABEXATE MESILATE, CEFEPIME DIHYDROCHLORIDE, ACYCLOVIR, LIDOCAINE, MEXILETINE HYDROCHLORIDE, OSELTAMIVIR PHOSPHATE, MEROPENEM TRIHYDRATE. Patient was hospitalized. Patient recovered.

Trisenox Side Effects Report #5127287-4
Trisenox side effect was reported by a Physician from JAPAN on Sept 26, 2006. Female patient, 68 years of age, was diagnosed with acute promyelocytic leukaemia and was treated with Trisenox. After drug was administered, patient experienced the following side effects: c-reactive protein increased, hypoalbuminaemia, hypoproteinaemia, white blood cell count decreased. Trisenox dosage: unknown. During the same period patient was treated with IMIDAPRIL HYDROCHLORIDE, AMLODIPINE BESYLATE, ZOLPIDEM TARTRATE. Patient recovered.

Trisenox Side Effects Report #4819831-9
Trisenox side effect was reported by a Physician from JAPAN on Oct 10, 2005. Female patient, 68 years of age, was diagnosed with acute promyelocytic leukaemia and was treated with Trisenox. After drug was administered, patient experienced the following side effects: white blood cell count decreased. Trisenox dosage: unknown. During the same period patient was treated with IMIDAPRIL HYDROCHLORIDE, AMLODIPINE BESYLATE. Patient recovered.

Trisenox Side Effects Report #5233587-X
Trisenox side effect was reported by a Physician from JAPAN on Jan 23, 2007. Female patient, 67 years of age, was diagnosed with acute promyelocytic leukaemia and was treated with Trisenox. After drug was administered, patient experienced the following side effects: alanine aminotransferase increased, anaemia, blood lactate dehydrogenase increased, febrile neutropenia, gamma-glutamyltransferase increased, hepatic function abnormal, platelet count decreased, white blood cell count decreased. Trisenox dosage: 7.95 MG QD INTRAVENOUS DRIP. Patient recovered.

Trisenox Side Effects Report #5062934-7
Trisenox side effect was reported by a Physician from JAPAN on July 07, 2006. Female patient, 67 years of age, was diagnosed with acute promyelocytic leukaemia and was treated with Trisenox. After drug was administered, patient experienced the following side effects: white blood cell count decreased. Trisenox dosage: 9 MG ROUTE: INTRAVENOUS DRIP QD INTRAVENOUS DRIP. Patient recovered.

Trisenox Side Effects Report #4629360-3
Trisenox side effect was reported by a Physician from on Mar 27, 2005. Female patient, 67 years of age, was diagnosed with acute promyelocytic leukaemia and was treated with Trisenox. After drug was administered, patient experienced the following side effects: white blood cell count decreased. Trisenox dosage: unknown. Patient recovered.

Trisenox Side Effects Report #5029125-7
Trisenox side effect was reported by a Physician from JAPAN on May 31, 2006. Female patient, 67 years of age, was diagnosed with acute promyelocytic leukaemia and was treated with Trisenox. After drug was administered, patient experienced the following side effects: white blood cell count decreased. Trisenox dosage: 9 MG QD INTRAVENOUS DRIP. Patient recovered.

Trisenox Side Effects Report #4661118-1
Trisenox side effect was reported by a Physician from on Apr 26, 2005. Male patient, 66 years of age, was diagnosed with acute promyelocytic leukaemia and was treated with Trisenox. After drug was administered, patient experienced the following side effects: body temperature increased, disseminated intravascular coagulation, dyspnoea, electrocardiogram qt corrected interval prolonged, leukocytosis, platelet count decreased, ventricular tachycardia, white blood cell count decreased. Trisenox dosage: unknown. During the same period patient was treated with NAFAMOSTAT, MAGNESIUM SULPHATE. Patient recovered.

Trisenox Side Effects Report #4830777-2
Trisenox side effect was reported by a Physician from JAPAN on Nov 01, 2005. Male patient, 66 years of age, was diagnosed with acute promyelocytic leukaemia and was treated with Trisenox. After drug was administered, patient experienced the following side effects: white blood cell count decreased. Trisenox dosage: 9.9 MG QD INTRAVENOUS DRIP. During the same period patient was treated with PRAVASTATIN, LANSOPRAZOLE, TAMSULOSIN HYDROCHLORIDE. Patient recovered.

Trisenox Side Effects Report #4844632-5
Trisenox side effect was reported by a Health Professional from JAPAN on Nov 14, 2005. Male patient, 66 years of age, was diagnosed with acute promyelocytic leukaemia and was treated with Trisenox. After drug was administered, patient experienced the following side effects: white blood cell count decreased. Trisenox dosage: unknown. Patient recovered.

Trisenox Side Effects Report #5136828-2
Trisenox side effect was reported by a Physician from JAPAN on Oct 05, 2006. Female patient, 62 years of age, was diagnosed with acute promyelocytic leukaemia and was treated with Trisenox. After drug was administered, patient experienced the following side effects: alanine aminotransferase increased, electrocardiogram qt corrected interval prolonged, electrocardiogram qt prolonged, hepatic function abnormal, white blood cell count decreased. Trisenox dosage: 6.975 MG QD INTRAVENOUS DRIP. Patient recovered.

Trisenox Side Effects Report #5127284-9
Trisenox side effect was reported by a Physician from JAPAN on Sept 26, 2006. Female patient, 61 years of age, was diagnosed with acute promyelocytic leukaemia and was treated with Trisenox. After drug was administered, patient experienced the following side effects: aspartate aminotransferase increased, c-reactive protein increased, condition aggravated, electrocardiogram qt prolonged, hepatic function abnormal, rash

, white blood cell count decreased. Trisenox dosage: 9.15 MG QD INTRAVENOUS DRIP. During the same period patient was treated with SULFAMETHOXAZOLE, FLUCONAZOLE. Patient recovered.

Trisenox Side Effects Report #5127286-2
Trisenox side effect was reported by a Physician from JAPAN on Sept 26, 2006. Female patient, 60 years of age, was diagnosed with acute promyelocytic leukaemia and was treated with Trisenox. After drug was administered, patient experienced the following side effects: white blood cell count decreased. Trisenox dosage: unknown. Patient recovered.

Trisenox Side Effects Report #4848089-X
Trisenox side effect was reported by a Physician from JAPAN on Nov 21, 2005. Female patient, 60 years of age, was diagnosed with acute promyelocytic leukaemia and was treated with Trisenox. After drug was administered, patient experienced the following side effects: blood creatine phosphokinase increased, haemoglobin decreased, herpes zoster, leukopenia, neutropenia, neutrophil count decreased, white blood cell count decreased. Trisenox dosage: 8.85 MG QD INTRAVENOUS DRIP. Patient was hospitalized. Patient recovered.

Trisenox Side Effects Report #5136829-4
Trisenox side effect was reported by a Physician from JAPAN on Oct 05, 2006. Female patient, 58 years of age, was diagnosed with acute promyelocytic leukaemia, prophylaxis and was treated with Trisenox. After drug was administered, patient experienced the following side effects: electrocardiogram qt prolonged, herpes zoster, white blood cell count decreased. Trisenox dosage: 6.66 MG QD INTRAVENOUS DRIP. During the same period patient was treated with METHOTREXATE. Patient recovered.

Trisenox Side Effects Report #5320867-2
Trisenox side effect was reported by a Physician from JAPAN on Apr 24, 2007. Female patient, 57 years of age, was diagnosed with acute promyelocytic leukaemia and was treated with Trisenox. After drug was administered, patient experienced the following side effects: alanine aminotransferase increased, aspartate aminotransferase increased, blood bilirubin increased, electrocardiogram qt prolonged, hepatic function abnormal, herpes zoster, white blood cell count decreased. Trisenox dosage: 8.475 MG QD INTRAVENOUS DRIP. During the same period patient was treated with RANITIDINE HYDROCHLORIDE, ALLOPURINOL, PRAVASTATIN, SULFAMETHOXAZOLE AND TRIMETHOPRIM, BROTIZOLAM, ETIZOLAM. Patient was hospitalized. Patient recovered.

Trisenox Side Effects Report #5087025-0
Trisenox side effect was reported by a Physician from JAPAN on Aug 09, 2006. Female patient, 57 years of age, was diagnosed with acute promyelocytic leukaemia and was treated with Trisenox. After drug was administered, patient experienced the following side effects: alanine aminotransferase increased, aspartate aminotransferase increased, c-reactive protein increased, headache

, hepatic function abnormal, platelet count decreased, rash

, white blood cell count decreased. Trisenox dosage: 7.77 MG QD INTRAVENOUS DRIP. Patient recovered.

Trisenox Side Effects Report #5127285-0
Trisenox side effect was reported by a Physician from JAPAN on Sept 27, 2006. Female patient, 57 years of age, was diagnosed with acute promyelocytic leukaemia and was treated with Trisenox. After drug was administered, patient experienced the following side effects: electrocardiogram qt prolonged, hepatic function abnormal, white blood cell count decreased. Trisenox dosage: 8.475 MG QD INTRAVENOUS DRIP. During the same period patient was treated with RANITIDINE HYDROCHLORIDE, ALLOPURINOL, PRAVASTATIN. Patient was hospitalized. Patient recovered.

Trisenox Side Effects Report #5147069-7
Trisenox side effect was reported by a Physician from JAPAN on Oct 20, 2006. Female patient, 57 years of age, was diagnosed with acute promyelocytic leukaemia and was treated with Trisenox. After drug was administered, patient experienced the following side effects: alanine aminotransferase increased, aspartate aminotransferase increased, electrocardiogram qt prolonged, hepatic function abnormal, herpes zoster, white blood cell count decreased. Trisenox dosage: 8.475 MG QD INTRAVENOUS DRIP. During the same period patient was treated with RANITIDINE HYDROCHLORIDE, ALLOPURINOL, PRAVASTATIN, SULFAMETHOXAZOLE, BROTIZOLAM, ETIZOLAM. Patient was hospitalized. Patient recovered.

Trisenox Side Effects Report #5116821-6
Trisenox side effect was reported by a Physician from JAPAN on Sept 08, 2006. Male patient, 53 years of age, was diagnosed with acute promyelocytic leukaemia and was treated with Trisenox. After drug was administered, patient experienced the following side effects: alanine aminotransferase increased, aspartate aminotransferase increased, blood calcium decreased, blood magnesium decreased, blood sodium decreased, neutrophil count decreased, white blood cell count decreased. Trisenox dosage: 4.425 MG QD INTRAVENOUS DRIP. During the same period patient was treated with GABEXATE MESILATE. Patient recovered.

Trisenox Side Effects Report #5133972-0
Trisenox side effect was reported by a Physician from JAPAN on Oct 02, 2006. Female patient, 53 years of age, was diagnosed with acute promyelocytic leukaemia and was treated with Trisenox. After drug was administered, patient experienced the following side effects: alanine aminotransferase increased, electrocardiogram qt prolonged, hepatic function abnormal, red blood cell count decreased, white blood cell count decreased. Trisenox dosage: 7.35 MG QD INTRAVENOUS DRIP. Patient recovered.

Trisenox Side Effects Report #5179503-0
Trisenox side effect was reported by a Physician from JAPAN on Nov 29, 2006. Female patient, 53 years of age, was diagnosed with acute promyelocytic leukaemia and was treated with Trisenox. After drug was administered, patient experienced the following side effects: alanine aminotransferase increased, electrocardiogram qt prolonged, haemoglobin decreased, hepatic function abnormal, red blood cell count decreased, white blood cell count decreased. Trisenox dosage: 7.35 MG QD INTRAVENOUS DRIP. Patient recovered.

Trisenox Side Effects Report #4853590-9
Trisenox side effect was reported by a Physician from JAPAN on Nov 30, 2005. Male patient, 48 years of age, was diagnosed with acute promyelocytic leukaemia and was treated with Trisenox. After drug was administered, patient experienced the following side effects: enteritis infectious, gastrointestinal disorder, haemoglobin decreased, hyperplasia, ileus, white blood cell count decreased. Trisenox dosage: 8.4 MG QD INTRAVENOUS. During the same period patient was treated with CHLORPROMAZINE, TRIHEXYPHENIDYL HYDROCHLORIDE, ZOTEPINE, FLUNITRAZEPAM, FAMOTIDINE, FLUCONAZOLE, GABEXATE MESILATE. Patient was hospitalized. Patient recovered.

Trisenox Side Effects Report #6088508-7
Trisenox side effect was reported by a Physician from JAPAN on Feb 09, 2009. Male patient, 46 years of age, was diagnosed with acute promyelocytic leukaemia and was treated with Trisenox. After drug was administered, patient experienced the following side effects: alanine aminotransferase increased, blood alkaline phosphatase increased, haemoglobin decreased, hepatic function abnormal, platelet count decreased, white blood cell count decreased. Trisenox dosage: 7.65 MG QD; INTRAVENOUS DRIP. During the same period patient was treated with CYTARABINE, METHOTREXATE, DEXAMETHASONE PHOSPHATE, FILGRASTIM. Patient was hospitalized. Patient recovered.

Trisenox Side Effects Report #6108579-9
Trisenox side effect was reported by a Health Professional from JAPAN on Feb 19, 2009. Male patient, 46 years of age, was diagnosed with acute promyelocytic leukaemia and was treated with Trisenox. After drug was administered, patient experienced the following side effects: alanine aminotransferase increased, blood alkaline phosphatase increased, haemoglobin decreased, hepatic function abnormal, platelet count decreased, white blood cell count decreased. Trisenox dosage: 7.65 MG QD INTRAVENOUS DRIP. During the same period patient was treated with CYTARABINE, METHOTREXATE, DEXAMETHASONE PHOSPHATE, FILGRASTIM. Patient was hospitalized and became disabled. Patient recovered.

Trisenox Side Effects Report #5114873-0
Trisenox side effect was reported by a Physician from JAPAN on Sept 05, 2006. Female patient, 43 years of age, was diagnosed with acute promyelocytic leukaemia and was treated with Trisenox. After drug was administered, patient experienced the following side effects: electrocardiogram qt corrected interval prolonged, electrocardiogram qt prolonged, hepatic function abnormal, white blood cell count decreased. Trisenox dosage: 8.19 MG QD INTRAVENOUS DRIP. During the same period patient was treated with POTASSIUM CHLORIDE, TEPRENONE, MAGNESIUM OXIDE. Patient recovered.

Trisenox Side Effects Report #5913581-3
Trisenox side effect was reported by a Physician from JAPAN on Sept 24, 2008. Female patient, 43 years of age, was diagnosed with acute promyelocytic leukaemia and was treated with Trisenox. After drug was administered, patient experienced the following side effects: alanine aminotransferase increased, aspartate aminotransferase increased, electrocardiogram qt prolonged, hepatic function abnormal, hyperglycaemia, ventricular extrasystoles, white blood cell count decreased. Trisenox dosage: 10.2 MG QD INTRAVENOUS DRIP. Patient was hospitalized. Patient recovered.

Trisenox Side Effects Report #5102981-X
Trisenox side effect was reported by a Physician from JAPAN on Aug 23, 2006. Male patient, 39 years of age, was diagnosed with acute promyelocytic leukaemia and was treated with Trisenox. After drug was administered, patient experienced the following side effects: alanine aminotransferase increased, aspartate aminotransferase increased, electrocardiogram qt corrected interval prolonged, hepatic function abnormal, hypernatraemia, hypokalaemia, white blood cell count decreased. Trisenox dosage: 10.98 MG QD INTRAVENOUS DRIP. During the same period patient was treated with CYTARABINE, METHOTREXATE, DEXAMETHASONE PHOSPHATE, ELECTROLYTE SOLUTION, RANITIDINE HYDROCHLORIDE. Patient recovered.

Trisenox Side Effects Report #4650014-1
Trisenox side effect was reported by a Physician from on Apr 11, 2005. Female patient, 35 years of age, was diagnosed with acute promyelocytic leukaemia and was treated with Trisenox. After drug was administered, patient experienced the following side effects: alanine aminotransferase increased, aspartate aminotransferase increased, white blood cell count decreased. Trisenox dosage: (10.38 MG, QD, 5X/WK), IVI. During the same period patient was treated with CLINDAMYCIN, PHENOBARBITAL, TERPRENONE. Patient was hospitalized. Patient recovered.

Trisenox Side Effects Report #4947900-1
Trisenox side effect was reported by a Physician from JAPAN on Feb 23, 2006. Male patient, 33 years of age, was diagnosed with acute promyelocytic leukaemia and was treated with Trisenox. After drug was administered, patient experienced the following side effects: platelet count decreased, white blood cell count decreased. Trisenox dosage: 10.8 MG QD INTRAVENOUS DRIP. During the same period patient was treated with HEPARIN, FAMOTIDINE, FLUCONAZOLE, SULFAMETHOXAZOLE, ACYCLOVIR. Patient was hospitalized. Patient recovered.

Trisenox Side Effects Report #5336511-4
Trisenox side effect was reported by a Physician from JAPAN on May 14, 2007. Female patient, 32 years of age, was diagnosed with acute promyelocytic leukaemia and was treated with Trisenox. After drug was administered, patient experienced the following side effects: alanine aminotransferase increased, aspartate aminotransferase increased, blood lactate dehydrogenase decreased, electrocardiogram qt prolonged, hepatic function abnormal, protein total decreased, rash

, white blood cell count decreased. Trisenox dosage: 7.05 MG QD INTRAVENOUS DRIP. During the same period patient was treated with ELECTROLYTE. Patient was hospitalized. Patient recovered.

Trisenox Side Effects Report #5084862-3
Trisenox side effect was reported by a Physician from JAPAN on Aug 01, 2006. Male patient, 30 years of age, was diagnosed with acute promyelocytic leukaemia and was treated with Trisenox. After drug was administered, patient experienced the following side effects: alanine aminotransferase increased, aspartate aminotransferase increased, c-reactive protein increased, electrocardiogram qt prolonged, febrile neutropenia, white blood cell count decreased. Trisenox dosage: 8.43 MG QD INTRAVENOUS DRIP. During the same period patient was treated with IMIPENEM CILASTATIN, BIFIDOBACTERIUM, LOPERAMIDE HYDROCHLORIDE, CEFEPIME DIHYDROCHLORIDE. Patient was hospitalized. Patient recovered.

Trisenox Side Effects Report #5691910-6
Trisenox side effect was reported by a Physician from JAPAN on Mar 18, 2008. Female patient, 26 years of age, was diagnosed with acute promyelocytic leukaemia and was treated with Trisenox. After drug was administered, patient experienced the following side effects: muscular weakness, white blood cell count decreased. Trisenox dosage: 6.6 MG QD INTRAVENOUS DRIP. Patient recovered.

Trisenox Side Effects Report #5705337-1
Trisenox side effect was reported by a Physician from JAPAN on Mar 28, 2008. Female patient, 26 years of age, was diagnosed with acute promyelocytic leukaemia and was treated with Trisenox. After drug was administered, patient experienced the following side effects: muscular weakness, white blood cell count decreased. Trisenox dosage: 6.6 MG QD INTRAVENOUS DRIP. Patient recovered.

Trisenox Side Effects Report #5070308-8
Trisenox side effect was reported by a Physician from JAPAN on July 18, 2006. Male patient, 54 years of age, was treated with Trisenox. After drug was administered, patient experienced the following side effects: white blood cell count decreased. Trisenox dosage: unknown. Patient recovered.

Trisenox and white blood cell count decreased

SideEffects101.com

Trisenox and white blood cell count decreased Patient Reports February 13, 2012

side effects of Trisenox